Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
RPX7009 (beta-lactamase inhibitor) is being studies in combination with a carbapenem biapenem to treat bacterial infections, including those due to multi-drug resistant bacteria.
Epistemonikos ID: 5a1d3b2a74d16f1b9d1801c4bf763a7ed65afdd7
First added on: May 11, 2024